Skip to main content

Prescription Drug Price Transparency Rulemaking Advisory Committee (HB 4005)

The Department of Consumer and Business Services (DCBS) adopted final rules implementing the 2018 Prescription Drug Price Transparency Act to provide notice and disclosure of information relating to the cost and pricing of prescription drugs in order to provide accountability for prescription drug pricing. The rule was adopted February 25, 2019, and became effective March 1, 2019.

Meetings and documents

Public comments received

Committee members


​​Committee contact

Jesse Ellis O'Brien
Senior Policy Analyst
Oregon Division of Financial Regulation


Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how